Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19

NCT04684446 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: AZD1222
BIOLOGICAL: rAd26-S

Sponsor

R-Pharm

Collaborators

[object Object]
[object Object]
[object Object]